Molecular classification of IDH-mutant glioblastomas based on gene expression profiles

gan Wu, Fan, Chai, Rui-Chao, Wang, Zhiliang, Liu, Yu-Qing, Zhao, Zheng, Li, Guan-Zhang, Jiang, Hao-Yu
Cyhoeddwyd yn Carcinogenesis (2019)

Prognostic power of a lipid metabolism gene panel for diffuse gliomas

gan Wu, Fan, Zhao, Zheng, Chai, Rui‐Chao, Liu, Yu‐Qing, Li, Guan‐Zhang, Jiang, Hao‐Yu, Jiang, Tao
Cyhoeddwyd yn J Cell Mol Med (2019)

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor

gan Wang, Zhi-liang, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Wang, Zheng, Zhang, Chuan-bao, Jiang, Tao
Cyhoeddwyd yn Oncoimmunology (2018)

Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma

gan Wang, Zhi-liang, Wang, Zheng, Li, Guan-zhang, Wang, Qiang-wei, Bao, Zhao-shi, Zhang, Chuan-bao, Jiang, Tao
Cyhoeddwyd yn Front Immunol (2019)

Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes

gan Wu, Fan, Liu, Yan-Wei, Li, Guan-Zhang, Zhai, You, Feng, Yue-Mei, Ma, Wen-Ping, Zhao, Zheng, Zhang, Wei
Cyhoeddwyd yn Br J Cancer (2021)

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme

gan Chen, Bao-Shi, Wang, Kuan-Yu, Yu, Shu-Qing, Zhang, Chuan-Bao, Li, Guan-Zhang, Wang, Zhi-Liang, Bao, Zhao-Shi
Cyhoeddwyd yn Oncol Lett (2020)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression

gan Liu, Han-jie, Hu, Hui-min, Li, Guan-zhang, Zhang, Ying, Wu, Fan, Liu, Xiu, Wang, Kuan-yu, Zhang, Chuan-bao, Jiang, Tao
Cyhoeddwyd yn Front Cell Dev Biol (2020)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas

gan Chang, Yu-Zhou, Li, Guan-Zhang, Pang, Bo, Zhang, Ke-Nan, Zhang, Xiao-Hui, Wang, Yong-Zhi, Jiang, Zhong-li, Chai, Rui-Chao
Cyhoeddwyd yn Front Cell Dev Biol (2020)

ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

gan Zhao, Zheng, Zhang, Ke-Nan, Chai, Rui-Chao, Wang, Kuan-Yu, Huang, Ruo-Yu, Li, Guan-Zhang, Wang, Yong-Zhi, Chen, Jing, Jiang, Tao
Cyhoeddwyd yn Dis Markers (2019)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas

gan Zhao, Zheng, Li, Guan‐Zhang, Liu, Yu‐Qing, Huang, Ruo‐Yu, Wang, Kuan‐Yu, Jiang, Hao‐Yu, Li, Ren‐Peng, Chai, Rui‐Chao, Zhang, Chuan‐Bao, Wu, Fan
Cyhoeddwyd yn J Cell Mol Med (2020)

Classification of diffuse lower‐grade glioma based on immunological profiling

gan Wu, Fan, Wang, Zhi‐Liang, Wang, Kuan‐Yu, Li, Guan‐Zhang, Chai, Rui‐Chao, Liu, Yu‐Qing, Jiang, Hao‐Yu, Zhai, You, Feng, Yue‐Mei, Zhao, Zheng, Zhang, Wei
Cyhoeddwyd yn Mol Oncol (2020)

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma

gan Chai, Rui-Chao, Li, Yi-Ming, Zhang, Ke-Nan, Chang, Yu-Zhou, Liu, Yu-Qing, Zhao, Zheng, Wang, Zhi-Liang, Chang, Yuan-Hao, Li, Guan-Zhang, Wang, Kuan-Yu, Wu, Fan, Wang, Yong-Zhi
Cyhoeddwyd yn JCI Insight (2019)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

gan Li, Guan-Zhang, Zhang, Ke-Nan, Wang, Zheng, Hu, Hui-Min, Wang, Zhi-Liang, Huang, Ruo-Yu, Jiang, Hao-Yu, Zhai, You, Feng, Yue-Mei, Chang, Yuan-Hao, Li, Ren-Peng, Wu, Fan, Zeng, Fan, Jiang, Tao, Zhang, Wei
Cyhoeddwyd yn Onco Targets Ther (2019)